GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells

Area of Science:

• Immunology
• Cell Biology
• Hematopoiesis

Background:

• Stem cell factor (SCF) is a key cytokine for hematopoiesis, binding to the c-kit receptor.
• Dendritic cells (DCs) express c-kit, but the SCF/c-kit axis role in DCs, especially in the bone marrow (BM), requires further investigation.
• Conventional DCs (cDCs) in human and mouse BM show higher c-kit expression in type 1 cDC subsets (cDC1s) than type 2 cDC subsets (cDC2s).

Purpose of the Study:

• To characterize c-kit expression and the SCF/c-kit axis in bone marrow-derived dendritic cells (BMdDCs).
• To investigate the functional impact of SCF/c-kit signaling on BMdDC survival, antigen presentation, and chemokine receptor expression.
• To evaluate the potential clinical implications of the SCF/c-kit axis in DC biology.

Main Methods:

• Characterization of c-kit expression in human and mouse conventional DCs (cDCs) from bone marrow (BM) and spleen.
• Generation and purification of BM-derived DCs (BMdDCs) using granulocyte-macrophage colony-stimulating factor (GM-CSF).
• Analysis of c-kit and SCF expression, cell survival upon SCF silencing, and functional assays (antigen presentation, CXCR4 expression).

Main Results:

• BMdDCs express c-kit and produce SCF, with upregulation upon GM-CSF withdrawal.
• SCF silencing significantly reduced BMdDC survival, indicating a prosurvival role.
• SCF did not affect antigen presentation or CXCR4 expression in BMdDCs.

Conclusions:

• The SCF/c-kit-mediated prosurvival circuit in DCs may be underestimated due to the common use of GM-CSF in in vitro cultures.
• DCs might rely more heavily on SCF in specific in vivo microenvironments.
• The SCF/c-kit axis in DCs has potential implications for graft-versus-host disease and antitumor immunity.